Literature DB >> 25784528

Narcolepsy with Cataplexy in an Elderly Woman.

Shingo Suzuki1, Takanori Uehara, Yoshiyuki Ohira, Masatomi Ikusaka.   

Abstract

A 72-year-old woman was referred for a 15-year history of brief attacks of generalized weakness that occurred when she was tense or startled. During these episodes, she squatted, closed her eyes, and had difficulty speaking, but there was no disturbance of consciousness. The cerebrospinal fluid level of orexin/hypocretin was low (92 ng/L), leading to a diagnosis of narcolepsy with cataplexy according to the International Classification of Sleep Disorders (ICSD)-2 criteria. Cataplexy should be considered for sudden attacks of weakness lasting less than 2 minutes and with no alteration of consciousness. Measurement of cerebrospinal fluid levels of orexin/hypocretin is recommended when the diagnosis is uncertain.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25784528      PMCID: PMC4510249          DOI: 10.1007/s11606-015-3277-7

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  10 in total

1.  A need for new treatments in narcolepsy.

Authors:  Luigi Ferini Strambi
Journal:  Lancet Neurol       Date:  2013-10-07       Impact factor: 44.182

2.  The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.

Authors:  Emmanuel Mignot; Gert Jan Lammers; Beth Ripley; Michele Okun; Sonia Nevsimalova; Sebastiaan Overeem; Jitka Vankova; Jed Black; John Harsh; Claudio Bassetti; Harald Schrader; Seiji Nishino
Journal:  Arch Neurol       Date:  2002-10

3.  Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults.

Authors:  Emmanuel Mignot; Ling Lin; Laurel Finn; Cecilia Lopes; Kathryn Pluff; Mary L Sundstrom; Terry Young
Journal:  Brain       Date:  2006-04-05       Impact factor: 13.501

4.  The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency.

Authors:  Sebastiaan Overeem; Sofie J van Nues; Wendy L van der Zande; Claire E Donjacour; Petra van Mierlo; Gert Jan Lammers
Journal:  Sleep Med       Date:  2010-12-08       Impact factor: 3.492

5.  Narcolepsy: clinical differences and association with other sleep disorders in different age groups.

Authors:  Sona Nevsimalova; Juraj Pisko; Jitka Buskova; David Kemlink; Iva Prihodova; Karel Sonka; Jelena Skibova
Journal:  J Neurol       Date:  2012-10-16       Impact factor: 4.849

6.  Effect of age on MSLT results in patients with narcolepsy-cataplexy.

Authors:  Y Dauvilliers; A Gosselin; J Paquet; J Touchon; M Billiard; J Montplaisir
Journal:  Neurology       Date:  2004-01-13       Impact factor: 9.910

Review 7.  Etiopathogenesis and neurobiology of narcolepsy: a review.

Authors:  Swarup Kumar; Haritha Sagili
Journal:  J Clin Diagn Res       Date:  2013-12-27

Review 8.  Hypocretin/orexin and narcolepsy: new basic and clinical insights.

Authors:  S Nishino; M Okuro; N Kotorii; E Anegawa; Y Ishimaru; M Matsumura; T Kanbayashi
Journal:  Acta Physiol (Oxf)       Date:  2009-06-25       Impact factor: 6.311

9.  Narcolepsy: a review.

Authors:  Gbolagade Sunmaila Akintomide; Hugh Rickards
Journal:  Neuropsychiatr Dis Treat       Date:  2011-09-08       Impact factor: 2.570

10.  Narcolepsy or Sleep Apnea?: Not Everything is What it Appears to be!

Authors:  Seithikurippu R Pandi-Perumal; Ravi Gupta; Jaime M Monti
Journal:  Front Neurol       Date:  2013-10-08       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.